Kirk Shepard compensation by year
PDS Biotechnology Summary Compensation Table · all 2 fiscal years held| Component | FY2024 | FY2025 |
|---|---|---|
| Salary | $426,346 | $463,500 |
| Bonus | $45,000 | $0 |
| Stock awards | $0 | $0 |
| Option awards | $840,000 | $193,500 |
| Non-equity incentive | $0 | $0 |
| Pension and deferred compensation | $0 | $0 |
| All other | $14,250 | $20,318 |
| Total | $1,325,596 | $677,318 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: PDS Biotechnology Corp DEF 14A filed June 26, 2026, accession 0001140361-26-026564, and prior-year filings.
How this page was built: the PDS Biotechnology Corp filed document, accession 0001140361-26-026564. Every figure is read from that document and cited to the page and table it appears in. Filed June 26, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 100,000 | $76,980 | — |
| Option | 150,000 | — | $1.79 |
| Option | 102,877 | — | $4.49 |
Per the Outstanding Equity Awards at Fiscal Year-End table in PDS Biotechnology Corp's FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
1 Form 4 line since the FY2025 proxy (filed June 26, 2026)current to 2026-11-21 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-11-16 | Grant or award derivative | — | 750,000 | $0.00 | 750,000 |
The 1 most recent of 1 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
PDS Biotechnology’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Frank Bedu-Addo | Chief Executive Officer | $828,307 |
| Kirk Shepard · this page | Chief Medical Officer | $677,318 |
| Stephan Toutain | Chief Operating Officer | $673,629 |
The full PDS Biotechnology compensation record
free company briefThis page is one person within PDS Biotechnology's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are PDS Biotechnology's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.